天原集團(002386.SZ):附屬將次氯酸鈉作為正式產品 加快含氯消毒劑系列產品開發
格隆匯2月17日丨天原集團(002386.SZ)公佈,自新冠肺炎疫情發生以來,公司積極履行社會責任,努力克服疫情期間面臨的原材料運輸、包裝等諸多困難,充分發揮資源技術優勢,調整生產計劃,迅速行動全力增加市場十分緊缺的高效消毒劑---次氯酸鈉原液生產,截止2月15日,公司已生產5%次氯酸鈉原液773噸,已向四川省內10多個地市捐贈5%次氯酸鈉原液427噸,面向社會銷售242噸。公司將根據疫情防控需要,繼續全力組織生產,為打贏這場全民參與的疫情防控阻擊戰貢獻更多天原力量。
公司下屬子公司海豐和鋭具備年產15萬噸次氯酸鈉能力,並於近期取得次氯酸鈉消毒液衞生許可證。根據疫情防控急需和未來消毒產品市場需求,海豐和鋭已將次氯酸鈉作為正式產品進行生產。在滿足大型公共場所對次氯酸鈉消毒原液需求的基礎上,將新投入部分裝置生產家庭等日常使用的小瓶包裝84消毒液。
此外,公司將利用好四川省將宜賓市打造成為全省醫用衞生材料產業基地的契機,加快含氯消毒劑等系列消毒劑的規劃和開發,豐富提升消毒系列產品的品種,更好滿足衞生防疫和人們高質量生活的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.